Post
NEJM.org
nejm.org
did:plc:mgwrki6irihfcatu2v347soc
In patients with localized colorectal cancer and PIK3CA hotspot mutations in exon 9 or 20, daily low-dose aspirin resulted in a significantly lower recurrence rate than placebo. ALASCCA phase 3 trial results: nej.md/4mpKXNp
#MedSky #Oncology
2025-09-17T22:36:09.110Z